UBS Group
ONCY

UBS Group’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

UBS Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-29,364
Closed -$14K – 8901
2015
Q3 		$14K Buy
29,364
+18,419
+168% +$10.5K ﹤0.01% 7048
2015
Q2 		$6K Sell
10,945
-4,980
-31% -$3.38K ﹤0.01% 7837
2015
Q1 		$11K Buy
15,925
+3,004
+23% +$1.93K ﹤0.01% 7608
2014
Q4 		$6K Buy
+12,921
New +$7.81K ﹤0.01% 8909

Other funds holding ONCY

NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
KWMG
King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return
CS
Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

UBS Group's ONCY Position: Q4 2015 in Review

UBS Group sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 29,364 shares — an estimated $14K sold.

UBS Group first reported a position in ONCY in Q4 2014 and held it in 4 quarters. The position peaked at $14K in Q3 2015. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • UBS Group reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • UBS Group sold 29,364 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $14K.
  • UBS Group first reported a position in ONCOLYTICS BIOTECH INC in Q4 2014 and held it in 4 quarters.
  • UBS Group's ONCOLYTICS BIOTECH INC position peaked at $14K in Q3 2015.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on UBS Group's 13F filing for Q4 2015, filed 16 Feb 2016.